Epigenomics AG 18.11.2015 18:30 Dissemination of a Voting Rights Announcement, transmitted by DGAP – a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ————————————————————————— Voting Rights: Release of Voting Rights Notifications (§ 21 para. 1 German Securities Trading Act – ‘WpHG’) in Accordance with § 26 para. […]
Author: mark
18. November 2015
Epigenomics AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
18. November 2015
Epigenomics AG Announces 2015 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights
DGAP-News: Epigenomics AG / Key word(s): 9-month figures 2015-11-18 / 07:30 Epigenomics AG Announces 2015 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights Berlin (Germany) and Germantown, MD (U.S.A.), November 18, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics company, today announced its financial […]
09. November 2015
Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer
DGAP-News: Epigenomics AG / Key word(s): Study results/Conference 2015-11-09 / 08:30 Press release Epigenomics AG: Novel panel of blood-based DNA methylation biomarkers shows promising results in the detection of lung cancer Epigenomics’ DNA methylation biomarkers demonstrate high sensitivity compared to commonly used protein biomarkers Being developed as a blood-based test for early lung cancer detection […]
04. November 2015
Epigenomics AG: FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test
DGAP-News: Epigenomics AG / Key word(s): Regulatory Admission 2015-11-04 / 20:30 Press release FDA requests further data for approval of Epigenomics’ blood based colorectal cancer screening test FDA provides recommendations for amending the application in order to make it approvable Further study on increased compliance and adherence of Epi proColon(R) expected Strategic commercialization partner Polymedco […]
02. November 2015
Epigenomics AG: Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting
DGAP-News: Epigenomics AG / Key word(s): Conference 2015-11-02 / 14:00 Press release Epigenomics AG to provide an update on blood-based epigenetic tests at the Association of Molecular Pathology (AMP) 2015 Annual Meeting Berlin (Germany) and Germantown, MD (U.S.A.), November 2, 2015 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), the German-American cancer molecular diagnostics […]
30. October 2015
Epigenomics AG: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG mit dem Ziel der europaweiten Verbreitung
Epigenomics AG / Veröffentlichung der Gesamtzahl der Stimmrechte 30.10.2015 18:15 Veröffentlichung der Gesamtzahl der Stimmrechte nach § 26a WpHG, übermittelt durch DGAP – ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent verantwortlich. ————————————————————————— Hiermit teilt die Epigenomics AG mit, dass die Gesamtzahl der Stimmrechte am Ende des Monats Oktober […]